Commentary: Who should be using ex vivo lung perfusion?
Publication
, Journal Article
Alderete, IS; Hartwig, MG
Published in: J Thorac Cardiovasc Surg
January 2024
Duke Scholars
Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
January 2024
Volume
167
Issue
1
Start / End Page
382 / 383
Location
United States
Related Subject Headings
- Respiratory System
- Perfusion
- Organ Preservation
- Lung Transplantation
- Lung
- Humans
- Extracorporeal Circulation
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Alderete, I. S., & Hartwig, M. G. (2024). Commentary: Who should be using ex vivo lung perfusion? J Thorac Cardiovasc Surg, 167(1), 382–383. https://doi.org/10.1016/j.jtcvs.2023.04.047
Alderete, Isaac S., and Matthew G. Hartwig. “Commentary: Who should be using ex vivo lung perfusion?” J Thorac Cardiovasc Surg 167, no. 1 (January 2024): 382–83. https://doi.org/10.1016/j.jtcvs.2023.04.047.
Alderete IS, Hartwig MG. Commentary: Who should be using ex vivo lung perfusion? J Thorac Cardiovasc Surg. 2024 Jan;167(1):382–3.
Alderete, Isaac S., and Matthew G. Hartwig. “Commentary: Who should be using ex vivo lung perfusion?” J Thorac Cardiovasc Surg, vol. 167, no. 1, Jan. 2024, pp. 382–83. Pubmed, doi:10.1016/j.jtcvs.2023.04.047.
Alderete IS, Hartwig MG. Commentary: Who should be using ex vivo lung perfusion? J Thorac Cardiovasc Surg. 2024 Jan;167(1):382–383.
Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
January 2024
Volume
167
Issue
1
Start / End Page
382 / 383
Location
United States
Related Subject Headings
- Respiratory System
- Perfusion
- Organ Preservation
- Lung Transplantation
- Lung
- Humans
- Extracorporeal Circulation
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences